Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab
'' American Medical Association''. This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References

Monoclonal antibodies {{monoclonal-antibody-stub